Mutations and thrombosis in essential thrombocythemia

Young platelet millionaires with essential thrombocythemia

(2021) Naseema Gangat et al.   AMERICAN JOURNAL OF HEMATOLOGY

Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

(2020) Ayalew Tefferi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management

(2020) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Mayo CALR mutation type classification guide using alpha helix propensity

(2018) Terra L. Lasho et al.   AMERICAN JOURNAL OF HEMATOLOGY

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

(2018) Natasha Szuber et al.   AMERICAN JOURNAL OF HEMATOLOGY

Refining prognostication of thrombosis in ET

(2016) Tiziano Barbui   AMERICAN JOURNAL OF HEMATOLOGY

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

(2014) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia

(2014) G. Finazzi et al.   BLOOD

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history

(2014) Naseema Gangat et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

(2011) A. Carobbio et al.   BLOOD

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY